As clinical trials evolve, External Control Arms (ECA) are becoming more common in the field of drug development. With the increasing availability of real-world data, Cytel is leading the way in using ECAs to streamline trials and improve regulatory acceptance. As technology advances, we can expect the role of ECAs to expand, offering even more ways to enhance the speed and efficiency of clinical trials.
For more information visit - https://cytel.com/solutions/sp....ecialty-areas/extern
Like
Comment
Share
